Brentuximab Vedotin: New Possibilities for Treatment of Relapses and Refractory Hodgkin’s Lymphomas

Klinicheskaya Onkogematologiya/Clinical Oncohematology - Russian Federation
doi 10.21320/2500-2139-2016-9-4-398-405
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Practical Medicine Publishing House

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy